메뉴 건너뛰기




Volumn 4, Issue 2, 2015, Pages 156-164

Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer

Author keywords

Multiplex diagnosis system; Oncogene fusion; RET fusion; ROS1 fusion; Tyrosine kinase inhibitor (TKI)

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 3;

EID: 84944447298     PISSN: 22186751     EISSN: 22264477     Source Type: Journal    
DOI: 10.3978/j.issn.2218-6751.2014.11.11     Document Type: Article
Times cited : (238)

References (53)
  • 1
    • 84875947292 scopus 로고    scopus 로고
    • New targetable oncogenes in non-small-cell lung cancer
    • Oxnard GR, Binder A, Jänne PA. New targetable oncogenes in non-small-cell lung cancer. J Clin Oncol 2013;31:1097-104.
    • (2013) J Clin Oncol , vol.31 , pp. 1097-1104
    • Oxnard, G.R.1    Binder, A.2    Jänne, P.A.3
  • 2
    • 84886787498 scopus 로고    scopus 로고
    • RET fusion gene: translation to personalized lung cancer therapy
    • Kohno T, Tsuta K, Tsuchihara K, et al. RET fusion gene: translation to personalized lung cancer therapy. Cancer Sci 2013;104:1396-400.
    • (2013) Cancer Sci , vol.104 , pp. 1396-1400
    • Kohno, T.1    Tsuta, K.2    Tsuchihara, K.3
  • 3
    • 84857969863 scopus 로고    scopus 로고
    • Chipping away at the lung cancer genome
    • Pao W, Hutchinson KE. Chipping away at the lung cancer genome. Nat Med 2012;18:349-51.
    • (2012) Nat Med , vol.18 , pp. 349-351
    • Pao, W.1    Hutchinson, K.E.2
  • 4
    • 84875937242 scopus 로고    scopus 로고
    • Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapies
    • Li T, Kung HJ, Mack PC, et al. Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapies. J Clin Oncol 2013;31:1039-49.
    • (2013) J Clin Oncol , vol.31 , pp. 1039-1049
    • Li, T.1    Kung, H.J.2    Mack, P.C.3
  • 5
    • 84875936053 scopus 로고    scopus 로고
    • ALK in lung cancer: past, present, and future
    • Shaw AT, Engelman JA. ALK in lung cancer: past, present, and future. J Clin Oncol 2013;31:1105-11.
    • (2013) J Clin Oncol , vol.31 , pp. 1105-1111
    • Shaw, A.T.1    Engelman, J.A.2
  • 6
    • 84857985225 scopus 로고    scopus 로고
    • RET, ROS1 and ALK fusions in lung cancer
    • Takeuchi K, Soda M, Togashi Y, et al. RET, ROS1 and ALK fusions in lung cancer. Nat Med 2012;18:378-81.
    • (2012) Nat Med , vol.18 , pp. 378-381
    • Takeuchi, K.1    Soda, M.2    Togashi, Y.3
  • 7
    • 84857929267 scopus 로고    scopus 로고
    • KIF5B-RET fusions in lung adenocarcinoma
    • Kohno T, Ichikawa H, Totoki Y, et al. KIF5B-RET fusions in lung adenocarcinoma. Nat Med 2012;18:375-7.
    • (2012) Nat Med , vol.18 , pp. 375-377
    • Kohno, T.1    Ichikawa, H.2    Totoki, Y.3
  • 8
    • 84862776857 scopus 로고    scopus 로고
    • Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies
    • Lipson D, Capelletti M, Yelensky R, et al. Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies. Nat Med 2012;18:382-4.
    • (2012) Nat Med , vol.18 , pp. 382-384
    • Lipson, D.1    Capelletti, M.2    Yelensky, R.3
  • 9
    • 84887445619 scopus 로고    scopus 로고
    • Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer
    • Vaishnavi A, Capelletti M, Le AT, et al. Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer. Nat Med 2013;19:1469-72.
    • (2013) Nat Med , vol.19 , pp. 1469-1472
    • Vaishnavi, A.1    Capelletti, M.2    Le, A.T.3
  • 10
    • 84902682450 scopus 로고    scopus 로고
    • Druggable oncogene fusions in invasive mucinous lung adenocarcinoma
    • Nakaoku T, Tsuta K, Ichikawa H, et al. Druggable oncogene fusions in invasive mucinous lung adenocarcinoma. Clin Cancer Res 2014;20:3087-93.
    • (2014) Clin Cancer Res , vol.20 , pp. 3087-3093
    • Nakaoku, T.1    Tsuta, K.2    Ichikawa, H.3
  • 12
    • 84905508021 scopus 로고    scopus 로고
    • FGFR1/3 tyrosine kinase fusions define a unique molecular subtype of non-small cell lung cancer
    • Wang R, Wang L, Li Y, et al. FGFR1/3 tyrosine kinase fusions define a unique molecular subtype of non-small cell lung cancer. Clin Cancer Res 2014;20:4107-14.
    • (2014) Clin Cancer Res , vol.20 , pp. 4107-4114
    • Wang, R.1    Wang, L.2    Li, Y.3
  • 13
    • 84878781242 scopus 로고    scopus 로고
    • Identification of targetable FGFR gene fusions in diverse cancers
    • Wu YM, Su F, Kalyana-Sundaram S, et al. Identification of targetable FGFR gene fusions in diverse cancers. Cancer Discov 2013;3:636-47.
    • (2013) Cancer Discov , vol.3 , pp. 636-647
    • Wu, Y.M.1    Su, F.2    Kalyana-Sundaram, S.3
  • 14
    • 84878783802 scopus 로고    scopus 로고
    • Identification of recurrent FGFR3 fusion genes in lung cancer through kinome-centred RNA sequencing
    • Majewski IJ, Mittempergher L, Davidson NM, et al. Identification of recurrent FGFR3 fusion genes in lung cancer through kinome-centred RNA sequencing. J Pathol 2013;230:270-6.
    • (2013) J Pathol , vol.230 , pp. 270-276
    • Majewski, I.J.1    Mittempergher, L.2    Davidson, N.M.3
  • 15
    • 84863230117 scopus 로고    scopus 로고
    • A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing
    • Ju YS, Lee WC, Shin JY, et al. A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing. Genome Res 2012;22:436-45.
    • (2012) Genome Res , vol.22 , pp. 436-445
    • Ju, Y.S.1    Lee, W.C.2    Shin, J.Y.3
  • 16
    • 84894574242 scopus 로고    scopus 로고
    • RET revisited: expanding the oncogenic portfolio
    • Mulligan LM. RET revisited: expanding the oncogenic portfolio. Nat Rev Cancer 2014;14:173-86.
    • (2014) Nat Rev Cancer , vol.14 , pp. 173-186
    • Mulligan, L.M.1
  • 17
    • 84896493186 scopus 로고    scopus 로고
    • RET-rearranged non-small-cell lung carcinoma: a clinicopathological and molecular analysis
    • Tsuta K, Kohno T, Yoshida A, et al. RET-rearranged non-small-cell lung carcinoma: a clinicopathological and molecular analysis. Br J Cancer 2014;110:1571-8.
    • (2014) Br J Cancer , vol.110 , pp. 1571-1578
    • Tsuta, K.1    Kohno, T.2    Yoshida, A.3
  • 18
    • 84899471648 scopus 로고    scopus 로고
    • ALK, ROS1 and RET fusions in 1139 lung adenocarcinomas: a comprehensive study of common and fusion pattern-specific clinicopathologic, histologic and cytologic features
    • Pan Y, Zhang Y, Li Y, et al. ALK, ROS1 and RET fusions in 1139 lung adenocarcinomas: a comprehensive study of common and fusion pattern-specific clinicopathologic, histologic and cytologic features. Lung Cancer 2014;84:121-6.
    • (2014) Lung Cancer , vol.84 , pp. 121-126
    • Pan, Y.1    Zhang, Y.2    Li, Y.3
  • 19
    • 84870748688 scopus 로고    scopus 로고
    • RET fusions define a unique molecular and clinicopathologic subtype of non-small-cell lung cancer
    • Wang R, Hu H, Pan Y, et al. RET fusions define a unique molecular and clinicopathologic subtype of non-small-cell lung cancer. J Clin Oncol 2012;30:4352-9.
    • (2012) J Clin Oncol , vol.30 , pp. 4352-4359
    • Wang, R.1    Hu, H.2    Pan, Y.3
  • 20
    • 84878858856 scopus 로고    scopus 로고
    • Response to Cabozantinib in patients with RET fusion-positive lung adenocarcinomas
    • Drilon A, Wang L, Hasanovic A, et al. Response to Cabozantinib in patients with RET fusion-positive lung adenocarcinomas. Cancer Discov 2013;3:630-5.
    • (2013) Cancer Discov , vol.3 , pp. 630-635
    • Drilon, A.1    Wang, L.2    Hasanovic, A.3
  • 21
    • 84894066256 scopus 로고    scopus 로고
    • A single-tube multiplexed assay for detecting ALK, ROS1, and RET fusions in lung cancer
    • Lira ME, Choi YL, Lim SM, et al. A single-tube multiplexed assay for detecting ALK, ROS1, and RET fusions in lung cancer. J Mol Diagn 2014;16:229-43.
    • (2014) J Mol Diagn , vol.16 , pp. 229-243
    • Lira, M.E.1    Choi, Y.L.2    Lim, S.M.3
  • 22
    • 84919910077 scopus 로고    scopus 로고
    • A mouse model of KIF5B-RET fusion-dependent lung tumorigenesis
    • Saito M, Ishigame T, Tsuta K, et al. A mouse model of KIF5B-RET fusion-dependent lung tumorigenesis. Carcinogenesis 2014;35:2452-6.
    • (2014) Carcinogenesis , vol.35 , pp. 2452-2456
    • Saito, M.1    Ishigame, T.2    Tsuta, K.3
  • 23
    • 84880749878 scopus 로고    scopus 로고
    • Identification of a lung adenocarcinoma cell line with CCDC6-RET fusion gene and the effect of RET inhibitors in vitro and in vivo
    • Suzuki M, Makinoshima H, Matsumoto S, et al. Identification of a lung adenocarcinoma cell line with CCDC6-RET fusion gene and the effect of RET inhibitors in vitro and in vivo. Cancer Sci 2013;104:896-903.
    • (2013) Cancer Sci , vol.104 , pp. 896-903
    • Suzuki, M.1    Makinoshima, H.2    Matsumoto, S.3
  • 24
    • 84870337408 scopus 로고    scopus 로고
    • Identification of CCDC6-RET fusion in the human lung adenocarcinoma cell line, LC-2/ad
    • Matsubara D, Kanai Y, Ishikawa S, et al. Identification of CCDC6-RET fusion in the human lung adenocarcinoma cell line, LC-2/ad. J Thorac Oncol 2012;7:1872-6.
    • (2012) J Thorac Oncol , vol.7 , pp. 1872-1876
    • Matsubara, D.1    Kanai, Y.2    Ishikawa, S.3
  • 25
    • 84876383602 scopus 로고    scopus 로고
    • A patient with lung adenocarcinoma and RET fusion treated with vandetanib
    • Gautschi O, Zander T, Keller FA, et al. A patient with lung adenocarcinoma and RET fusion treated with vandetanib. J Thorac Oncol 2013;8:e43-4.
    • (2013) J Thorac Oncol , vol.8 , pp. e43-e44
    • Gautschi, O.1    Zander, T.2    Keller, F.A.3
  • 26
    • 84865441368 scopus 로고    scopus 로고
    • Identifying and targeting ROS1 gene fusions in non-small cell lung cancer
    • Davies KD, Le AT, Theodoro MF, et al. Identifying and targeting ROS1 gene fusions in non-small cell lung cancer. Clin Cancer Res 2012;18:4570-9.
    • (2012) Clin Cancer Res , vol.18 , pp. 4570-4579
    • Davies, K.D.1    Le, A.T.2    Theodoro, M.F.3
  • 27
    • 84881245421 scopus 로고    scopus 로고
    • Molecular pathways: ROS1 fusion proteins in cancer
    • Davies KD, Doebele RC. Molecular pathways: ROS1 fusion proteins in cancer. Clin Cancer Res 2013;19:4040-5.
    • (2013) Clin Cancer Res , vol.19 , pp. 4040-4045
    • Davies, K.D.1    Doebele, R.C.2
  • 28
    • 84905029258 scopus 로고    scopus 로고
    • Comprehensive molecular profiling of lung adenocarcinoma
    • Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature 2014;511:543-50.
    • (2014) Nature , vol.511 , pp. 543-550
  • 29
    • 84868309107 scopus 로고    scopus 로고
    • The transcriptional landscape and mutational profile of lung adenocarcinoma
    • Seo JS, Ju YS, Lee WC, et al. The transcriptional landscape and mutational profile of lung adenocarcinoma. Genome Res 2012;22:2109-19.
    • (2012) Genome Res , vol.22 , pp. 2109-2119
    • Seo, J.S.1    Ju, Y.S.2    Lee, W.C.3
  • 30
    • 84875224942 scopus 로고    scopus 로고
    • ROS1-rearranged lung cancer: a clinicopathologic and molecular study of 15 surgical cases
    • Yoshida A, Kohno T, Tsuta K, et al. ROS1-rearranged lung cancer: a clinicopathologic and molecular study of 15 surgical cases. Am J Surg Pathol 2013;37:554-62.
    • (2013) Am J Surg Pathol , vol.37 , pp. 554-562
    • Yoshida, A.1    Kohno, T.2    Tsuta, K.3
  • 31
    • 84905815103 scopus 로고    scopus 로고
    • Clinical and the prognostic characteristics of lung adenocarcinoma patients with ROS1 fusion in comparison with other driver mutations in East Asian populations
    • Chen YF, Hsieh MS, Wu SG, et al. Clinical and the prognostic characteristics of lung adenocarcinoma patients with ROS1 fusion in comparison with other driver mutations in East Asian populations. J Thorac Oncol 2014;9:1171-9.
    • (2014) J Thorac Oncol , vol.9 , pp. 1171-1179
    • Chen, Y.F.1    Hsieh, M.S.2    Wu, S.G.3
  • 32
    • 84863338079 scopus 로고    scopus 로고
    • ROS1 rearrangements define a unique molecular class of lung cancers
    • Bergethon K, Shaw AT, Ou SH, et al. ROS1 rearrangements define a unique molecular class of lung cancers. J Clin Oncol 2012;30:863-70.
    • (2012) J Clin Oncol , vol.30 , pp. 863-870
    • Bergethon, K.1    Shaw, A.T.2    Ou, S.H.3
  • 33
    • 84873927764 scopus 로고    scopus 로고
    • Mouse model for ROS1-rearranged lung cancer
    • Arai Y, Totoki Y, Takahashi H, et al. Mouse model for ROS1-rearranged lung cancer. PLoS One 2013;8:e56010.
    • (2013) PLoS One , vol.8
    • Arai, Y.1    Totoki, Y.2    Takahashi, H.3
  • 34
    • 84878975043 scopus 로고    scopus 로고
    • Complete metabolic response in a patient with repeatedly relapsed non-small cell lung cancer harboring ROS1 gene rearrangement after treatment with crizotinib
    • Bos M, Gardizi M, Schildhaus HU, et al. Complete metabolic response in a patient with repeatedly relapsed non-small cell lung cancer harboring ROS1 gene rearrangement after treatment with crizotinib. Lung Cancer 2013;81:142-3.
    • (2013) Lung Cancer , vol.81 , pp. 142-143
    • Bos, M.1    Gardizi, M.2    Schildhaus, H.U.3
  • 35
    • 84866749575 scopus 로고    scopus 로고
    • Response to crizotinib in ROS1-rearranged non-small-cell lung cancer
    • Sep 20, author reply 3426
    • Komiya T, Thomas A, Khozin S, et al. Response to crizotinib in ROS1-rearranged non-small-cell lung cancer. J Clin Oncol. 2012 Sep 20;30:3425-6; author reply 3426.
    • (2012) J Clin Oncol , vol.30 , pp. 3425-3426
    • Komiya, T.1    Thomas, A.2    Khozin, S.3
  • 36
    • 84908200713 scopus 로고    scopus 로고
    • Dramatic Response to Crizotinib in ROS1 Fluorescent In Situ Hybridization-and Immunohistochemistry-Positive Lung Adenocarcinoma: A Case Series
    • Chiari R, Buttitta F, Iacono D, et al. Dramatic Response to Crizotinib in ROS1 Fluorescent In Situ Hybridization-and Immunohistochemistry-Positive Lung Adenocarcinoma: A Case Series. Clin Lung Cancer 2014;15:470-4.
    • (2014) Clin Lung Cancer , vol.15 , pp. 470-474
    • Chiari, R.1    Buttitta, F.2    Iacono, D.3
  • 37
    • 84881662088 scopus 로고    scopus 로고
    • The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations
    • Tsuta K, Kawago M, Inoue E, et al. The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations. Lung Cancer 2013;81:371-6.
    • (2013) Lung Cancer , vol.81 , pp. 371-376
    • Tsuta, K.1    Kawago, M.2    Inoue, E.3
  • 38
    • 84871969337 scopus 로고    scopus 로고
    • Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients
    • Yoshizawa A, Sumiyoshi S, Sonobe M, et al. Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients. J Thorac Oncol 2013;8:52-61.
    • (2013) J Thorac Oncol , vol.8 , pp. 52-61
    • Yoshizawa, A.1    Sumiyoshi, S.2    Sonobe, M.3
  • 39
    • 84901895449 scopus 로고    scopus 로고
    • Multidriver mutation analysis in pulmonary mucinous adenocarcinoma in Taiwan: identification of a rare CD74-NRG1 translocation case
    • Gow CH, Wu SG, Chang YL, et al. Multidriver mutation analysis in pulmonary mucinous adenocarcinoma in Taiwan: identification of a rare CD74-NRG1 translocation case. Med Oncol 2014;31:34.
    • (2014) Med Oncol , vol.31 , pp. 34
    • Gow, C.H.1    Wu, S.G.2    Chang, Y.L.3
  • 40
    • 78650451788 scopus 로고    scopus 로고
    • Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer
    • Weiss J, Sos ML, Seidel D, et al. Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer. Sci Transl Med 2010;2:62ra93.
    • (2010) Sci Transl Med , vol.2
    • Weiss, J.1    Sos, M.L.2    Seidel, D.3
  • 41
    • 84882709305 scopus 로고    scopus 로고
    • Inhibitor-sensitive FGFR2 and FGFR3 mutations in lung squamous cell carcinoma
    • Liao RG, Jung J, Tchaicha J, et al. Inhibitor-sensitive FGFR2 and FGFR3 mutations in lung squamous cell carcinoma. Cancer Res 2013;73:5195-205.
    • (2013) Cancer Res , vol.73 , pp. 5195-5205
    • Liao, R.G.1    Jung, J.2    Tchaicha, J.3
  • 42
    • 84865805666 scopus 로고    scopus 로고
    • Transforming fusions of FGFR and TACC genes in human glioblastoma
    • Singh D, Chan JM, Zoppoli P, et al. Transforming fusions of FGFR and TACC genes in human glioblastoma. Science 2012;337:1231-5.
    • (2012) Science , vol.337 , pp. 1231-1235
    • Singh, D.1    Chan, J.M.2    Zoppoli, P.3
  • 43
    • 84901002216 scopus 로고    scopus 로고
    • Will the Requirement by the US FDA to Simultaneously Co-Develop Companion Diagnostics (CDx) Delay the Approval of Receptor Tyrosine Kinase Inhibitors for RTK-Rearranged (ROS1-, RET-, AXL-, PDGFR-a-, NTRK1-) Non-Small Cell Lung Cancer Globally?
    • Ou SH, Soo RA, Kubo A, et al. Will the Requirement by the US FDA to Simultaneously Co-Develop Companion Diagnostics (CDx) Delay the Approval of Receptor Tyrosine Kinase Inhibitors for RTK-Rearranged (ROS1-, RET-, AXL-, PDGFR-a-, NTRK1-) Non-Small Cell Lung Cancer Globally? Front Oncol 2014;4:58.
    • (2014) Front Oncol , vol.4 , pp. 58
    • Ou, S.H.1    Soo, R.A.2    Kubo, A.3
  • 44
    • 84897864510 scopus 로고    scopus 로고
    • Development of anaplastic lymphoma kinase (ALK) inhibitors and molecular diagnosis in ALK rearrangement-positive lung cancer
    • Iwama E, Okamoto I, Harada T, et al. Development of anaplastic lymphoma kinase (ALK) inhibitors and molecular diagnosis in ALK rearrangement-positive lung cancer. Onco Targets Ther 2014;7:375-85.
    • (2014) Onco Targets Ther , vol.7 , pp. 375-385
    • Iwama, E.1    Okamoto, I.2    Harada, T.3
  • 45
    • 84899989532 scopus 로고    scopus 로고
    • Immunohistochemical detection of ROS1 is useful for identifying ROS1 rearrangements in lung cancers
    • Yoshida A, Tsuta K, Wakai S, et al. Immunohistochemical detection of ROS1 is useful for identifying ROS1 rearrangements in lung cancers. Mod Pathol 2014;27:711-20.
    • (2014) Mod Pathol , vol.27 , pp. 711-720
    • Yoshida, A.1    Tsuta, K.2    Wakai, S.3
  • 46
    • 84865089246 scopus 로고    scopus 로고
    • Analysis of receptor tyrosine kinase ROS1-positive tumors in nonsmall cell lung cancer: identification of a FIG-ROS1 fusion
    • Rimkunas VM, Crosby KE, Li D, et al. Analysis of receptor tyrosine kinase ROS1-positive tumors in nonsmall cell lung cancer: identification of a FIG-ROS1 fusion. Clin Cancer Res 2012;18:4449-57.
    • (2012) Clin Cancer Res , vol.18 , pp. 4449-4457
    • Rimkunas, V.M.1    Crosby, K.E.2    Li, D.3
  • 47
    • 84887491073 scopus 로고    scopus 로고
    • Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
    • Frampton GM, Fichtenholtz A, Otto GA, et al. Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing. Nat Biotechnol 2013;31:1023-31.
    • (2013) Nat Biotechnol , vol.31 , pp. 1023-1031
    • Frampton, G.M.1    Fichtenholtz, A.2    Otto, G.A.3
  • 48
    • 84904211802 scopus 로고    scopus 로고
    • Molecular analysis for therapy choice: NCI MATCH
    • Conley BA, Doroshow JH. Molecular analysis for therapy choice: NCI MATCH. Semin Oncol 2014;41:297-9.
    • (2014) Semin Oncol , vol.41 , pp. 297-299
    • Conley, B.A.1    Doroshow, J.H.2
  • 49
    • 84922769881 scopus 로고    scopus 로고
    • Detecting ALK, ROS1 and RET fusion genes in cell block samples
    • Zhao C, Li X, Li J, et al. Detecting ALK, ROS1 and RET fusion genes in cell block samples. Transl Oncol 2014;7:363-7.
    • (2014) Transl Oncol , vol.7 , pp. 363-367
    • Zhao, C.1    Li, X.2    Li, J.3
  • 50
    • 84925582188 scopus 로고    scopus 로고
    • Anchored multiplex PCR for targeted next-generation sequencing
    • Zheng Z, Liebers M, Zhelyazkova B, et al. Anchored multiplex PCR for targeted next-generation sequencing. Nat Med 2014;20:1479-84.
    • (2014) Nat Med , vol.20 , pp. 1479-1484
    • Zheng, Z.1    Liebers, M.2    Zhelyazkova, B.3
  • 51
    • 84887497121 scopus 로고    scopus 로고
    • The quest to overcome resistance to EGFR-targeted therapies in cancer
    • Chong CR, Jänne PA. The quest to overcome resistance to EGFR-targeted therapies in cancer. Nat Med 2013;19:1389-400.
    • (2013) Nat Med , vol.19 , pp. 1389-1400
    • Chong, C.R.1    Jänne, P.A.2
  • 52
    • 84879088863 scopus 로고    scopus 로고
    • Acquired resistance to crizotinib from a mutation in CD74-ROS1
    • Awad MM, Katayama R, McTigue M, et al. Acquired resistance to crizotinib from a mutation in CD74-ROS1. N Engl J Med 2013;368:2395-401.
    • (2013) N Engl J Med , vol.368 , pp. 2395-2401
    • Awad, M.M.1    Katayama, R.2    McTigue, M.3
  • 53
    • 84899472081 scopus 로고    scopus 로고
    • Molecular mechanisms underlying oncogenic RET fusion in lung adenocarcinoma
    • Mizukami T, Shiraishi K, Shimada Y, et al. Molecular mechanisms underlying oncogenic RET fusion in lung adenocarcinoma. J Thorac Oncol 2014;9:622-30.
    • (2014) J Thorac Oncol , vol.9 , pp. 622-630
    • Mizukami, T.1    Shiraishi, K.2    Shimada, Y.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.